TREACE JOHN R
Known title: DirectorCIK: 0001185249
Associated companies
Transaction History
| TMCI | ▼ Sell | Open Market | 18,966 | $269K | 5/9/2022 | View on chart |
| TMCI | ▼ Sell | Open Market | 18,415 | $280K | 5/9/2022 | View on chart |
| TMCI | ▼ Sell | Open Market | 307 | $5K | 5/9/2022 | View on chart |
| TMCI | ▼ Sell | Open Market | 37,312 | $496K | 5/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Treace Medical Shares Five-Year Bunion Study Results
Treace Medical Concepts published five-year clinical results for its bunion treatment, aiming to strengthen evidence for broader adoption. This scientific update provides context for the stock's current position, which is trading near a key support level and below the average analyst price target.
Treace Medical Shares Five-Year Bunion Study Results. Treace Medical Concepts published five-year clinical results for its bunion treatment, aiming to strengthen evidence for broader adoption. This scientific update provides context for the stock's current position, which is trading near a key support level and below the average analyst price target.